Our research activities are consistently focused on improving patients’ quality of life. In the field of transdermal drug delivery, we currently market systems for the treatment of angina pectoris and for pain management, while additional drug delivery systems—designed for twice-weekly or once-weekly administration—are in development.
Leveraging the same technologies, we are also actively developing a range of over-the-counter (OTC) products.
Research Programs
We collaborate closely with leading research institutes in Greece and internationally, continuously monitoring and contributing to advancements in pharmaceutical research.
Intellectual Property
Our intellectual property portfolio includes a substantial number of granted patents covering the full spectrum of our technologies and products. In parallel, numerous additional patent applications are currently under review worldwide.